Latest Breaking News On - Phase 2 her2climb trial nct02614794 - Page 1 : vimarsana.com

Sarah Sammons, MD, discusses research efforts in breast cancer focused on HER2-directed therapeutic approaches with central nervous system activity.

United statesDana farber cancer instituteSan antonioSarah sammonsMemorial sloan kettering cancer centerMetastatic breast cancer programAntonio breast cancerAntonio breast cancer symposiumPhase 2 her2climb trial nct02614794Phase 3 her2climb 02 trial nct039756472023 san antonio breast cancer symposium